Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 919 of 1,261
  1. US 8198042

    CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV infection

    THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services · Granted Jun 12, 2012 · Expires Jun 7, 2032

    granted
  2. US 8198244

    Regulation of skin characteristics by DICKKOPF1 (DKK1)

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 12, 2012 · Expires Jun 7, 2032

    granted
  3. US 8198255

    SiRNA-mediated inhibition of doublecortin and Ca2+/calmodulin-dependent kinase-like-1

    The Board of Regents of the University of Oklahoma · Granted Jun 12, 2012 · Expires Jun 7, 2032

    granted
  4. US 8198402

    Smoothened polypeptides and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 12, 2012 · Expires Jun 7, 2032

    granted
  5. US 8198254

    Annexin A9 (ANXA9) biomarker and therapeutic target in epithelial cancer

    The Regents of the University of California · Granted Jun 12, 2012 · Expires Jun 7, 2032

    granted
  6. US 8197870

    Depolymerization extraction of compounds from birch bark

    Regents of the University of Minnesota · Granted Jun 12, 2012 · Expires Jun 7, 2032

    granted
  7. US 8198469

    Crystalline forms of tigecycline and processes for preparation thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 12, 2012 · Expires Jun 7, 2032

    granted
  8. US 8198406

    Methods and compositions for inhibiting angiogenesis

    Northwestern University · Granted Jun 12, 2012 · Expires Jun 7, 2032

    granted
  9. US 8198242

    Variants of C-type natriuretic peptide

    BIOMARIN PHARMACEUTICAL INC. · Granted Jun 12, 2012 · Expires Jun 7, 2032

    granted
  10. US 8197823

    Vaccine for porcine reproductive and respiratory syndrome, a preparion method and use thereof

    China Animal Disease Control Center · Granted Jun 12, 2012 · Expires Jun 7, 2032

    granted
  11. US 8197818

    EML4-ALK fusion gene

    CUREGENE K.K. · Granted Jun 12, 2012 · Expires Jun 7, 2032

    granted
  12. US 8198304

    Guanidine-containing compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Jun 12, 2012 · Expires Jun 7, 2032

    granted
  13. US 8193306

    Methods for preparing polymeric reagents and compositions of polymeric reagents

    Nektar Therapeutics · Granted Jun 5, 2012 · Expires May 31, 2032

    granted
  14. US 8193309

    Compositions and methods for preventing or treating cancer

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jun 5, 2012 · Expires May 31, 2032

    granted
  15. US 8193181

    Xinafoate salt of N4-(2,2-difluoro-4H-benzo[1,4]oxazin-3-one)-6-yl]-5-fluoro-N2-[3-(methylaminocarbonylmethyleneoxy) phenyl]2,4-pyrimidinediamine

    Rigel Pharmaceuticals, Inc. · Granted Jun 5, 2012 · Expires May 31, 2032

    granted
  16. US 8193167

    Pharmacologically active agents containing esterified phosphonates and methods for use thereof

    The United States of America—Department of Veterans Affairs · Granted Jun 5, 2012 · Expires May 31, 2032

    granted
  17. US 8193357

    Androgen receptor modulator compounds

    Ligand Pharmaceuticals Incorporated · Granted Jun 5, 2012 · Expires May 31, 2032

    granted
  18. US 8192720

    Compositions and methods for detection, prevention, and treatment of anthrax and other infectious diseases

    BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE OF THE UNIVERSITY OF NEVADA, RENO · Granted Jun 5, 2012 · Expires May 31, 2032

    granted
  19. US 8193312

    Bone morphogenic protein binding peptide

    The Regents of the University of California · Granted Jun 5, 2012 · Expires May 31, 2032

    granted
  20. US 8193330

    Polynucleotides comprising Neurogenin3 promoter and bHLH encoding domains

    The Regents of the University of California · Granted Jun 5, 2012 · Expires May 31, 2032

    granted
  21. US 8193197

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Jun 5, 2012 · Expires May 31, 2032

    granted
  22. US 8193339

    Synthesis of β-nucleosides

    PHARMAESSENTIA CORPORATION · Granted Jun 5, 2012 · Expires May 31, 2032

    granted
  23. US 8193204

    Solid forms of (S)-ethyl 2-amino-3-(4-(2-amino-6-((R)-1- (4-chloro-2-(3-methyl-1H-pyrazol-1-YL)phenyl)2,2,2-trifluoroethoxy)-pyrimidin-4-YL)phenyl)propanoate and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted Jun 5, 2012 · Expires May 31, 2032

    granted
  24. US 8193151

    Methods for treating atrial or ventricular arrhythmias

    Northwestern University · Granted Jun 5, 2012 · Expires May 31, 2032

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.